312 related articles for article (PubMed ID: 19300209)
1. In favor of the Jarnagin-Blumgart classification.
Ramacciato G; Nigri G; Ravaioli M; Del Gaudio M
Ann Surg; 2009 Apr; 249(4):697-8; author reply 698-9. PubMed ID: 19300209
[No Abstract] [Full Text] [Related]
2. The current management of hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; Blumgart LH
Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
[No Abstract] [Full Text] [Related]
3. Extrahepatic cholangiocarcinoma: current surgical strategy.
Boutros C; Somasundar P; Espat NJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
[TBL] [Abstract][Full Text] [Related]
4. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
5. A new technique for assessing the resectability of hilar cholangiocarcinoma: lifting of the umbilical portion of the portal vein.
Shirai Y; Yamai K; Ohtani T; Tsukada K; Hatakeyama K
J Am Coll Surg; 1997 Jan; 184(1):80-3. PubMed ID: 8989306
[No Abstract] [Full Text] [Related]
6. Staging for intrahepatic cholangiocarcinoma.
Kokudo N; Arita J
Liver Int; 2010 Aug; 30(7):931-3. PubMed ID: 20408948
[No Abstract] [Full Text] [Related]
7. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
8. [Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance].
Gavrilovici V; Grecu F; Seripcariu V; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):412-7. PubMed ID: 21870733
[TBL] [Abstract][Full Text] [Related]
9. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and treatment of bile duct carcinoma.
Chung C; Bautista N; O'Connell TX
Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
[TBL] [Abstract][Full Text] [Related]
11. Place of surgery in opisthorchiasis associated cholangiocarcinoma.
Bhudhisawasdi V
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():85-90. PubMed ID: 9656356
[No Abstract] [Full Text] [Related]
12. Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome.
D'Angelica MI; Jarnagin WR; Blumgart LH
Surg Today; 2004; 34(11):885-90. PubMed ID: 15526120
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment for hilar cholangiocarcinoma].
Arai T; Nagino M; Nimura Y
Nihon Rinsho; 2006 Jan; 64 Suppl 1():476-8. PubMed ID: 16457308
[No Abstract] [Full Text] [Related]
14. [Extrahepatic cholangiocarcinoma: current state of palliation therapy].
Wolkersdörfer GW; Berr F; Nawara C; Emmanuel K
Zentralbl Chir; 2012 Dec; 137(6):522-6. PubMed ID: 22511020
[TBL] [Abstract][Full Text] [Related]
15. Distal cholangiocarcinoma.
Liu K
J Surg Oncol; 2007 Mar; 95(3):192-3. PubMed ID: 17323332
[No Abstract] [Full Text] [Related]
16. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
Baton O; Azoulay D; Adam DV; Castaing D
J Am Coll Surg; 2007 Feb; 204(2):250-60. PubMed ID: 17254929
[TBL] [Abstract][Full Text] [Related]
17. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
18. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
[TBL] [Abstract][Full Text] [Related]
19. Right trisectionectomy with caudate lobectomy and extrahepatic bile duct resection for type Y perihilar cholangiocarcinoma.
Jeddou H; Tzedakis S; Boudjema K
J Visc Surg; 2022 Dec; 159(6):502-510. PubMed ID: 35690583
[No Abstract] [Full Text] [Related]
20. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
